Form 4 for EVH Evolent Health, Inc.
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001628908-22-000029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-01 | EVH | Tutewohl Steve | COO | A - Grant | $0.00 | +20.0K | 118.8K | +20% | $0 |
| D | 2022-03-03 | 2022-03-01 | EVH | Tutewohl Steve | COO | S - Sale+OE | $27.41 | -5,388 | 114.8K | -4% | -$147.7K |
| D | 2022-03-03 | 2022-03-01 | EVH | Tutewohl Steve | COO | M - OptEx | $13.29 | +5,388 | 121.1K | +5% | +$71.6K |
| D | 2022-03-03 | 2022-03-01 | EVH | Tutewohl Steve | COO | F - Tax | $27.40 | -4,005 | 114.8K | -3% | -$109.7K |
| D | 2022-03-03 | 2022-03-01 | EVH | Tutewohl Steve | COO | M - OptEx | $0.00 | -5,388 | 5,388 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-03-01 | A | A | 20,000 | $0.00 | 118,843 | D | — | — | (F1) Represents restricted stock units granted to Mr. Tutewohl pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. (F2) Securities vest at a rate of 34% on March 1, 2023, and 33 % on March 1, 2024, and March 1, 2025. (F3) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 2 | Common | Class A Common Stock | 2022-03-01 | S | D | 5,388 | $27.41 | 114,838 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.71 to $28.02, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F3) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 3 | Common | Class A Common Stock | 2022-03-01 | M | A | 5,388 | $13.29 | 121,130 | D | — | — | (F3) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 4 | Common | Class A Common Stock | 2022-03-01 | F | D | 4,005 | $27.40 | 114,838 | D | — | — | (F4) This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. (F3) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 5 | Derivative | Class A Common Stock Option (right to buy) | 2022-03-01 | M | D | 5,388 | $0.00 | 5,388 | D | $13.29 · — to 2029-03-01 | 5,388 Class A Common Stock | (F7) The Class A Common Stock Options exercised vested on March 1, 2022. |